Abstract | Erectile dysfunction (ED) in men and sexual dysfunction in men and women are common after cystectomy and urinary diversion. Research has focused on both qualifying the prevalence of ED following cystectomy and identifying surgical approaches to limit sexual dysfunction after surgery, but most studies have been limited by small patient populations, an absence of control groups, and a lack of adjustment for confounding factors. Similarly, quality of life (QoL) research studies have also emerged in the context of bladder cancer and cystectomy, and increase our understanding of sexual outcomes associated with cystectomy. A number of instruments for collection of patient-reported outcomes among patients with bladder cancer treated with cystectomy are available for the assessment of condition-specific and procedurespecific QoL. However, other factors that negatively affect sexual function after removal of the bladder, such as psychological issues, age, and health-related competing risks for ED, body image, partner response, and change in life course and sexual priorities, have received less attention. Nevertheless, ED and sexual dysfunction are important complications of cystectomy and urinary diversion. Although changes in the approach to surgery, such as nerve-sparing cystectomy, might improve outcomes, evaluation and management of the source factors of ED and sexual dysfunction are necessary to optimize recovery of function.
Introduction
Cystectomy is a common urological surgery performed for a number of indications, including muscle-invasive bladder cancer (MIBC), recurrent and recalcitrant nonmuscle-invasive bladder cancer (NMIBC), radiation injury, and severe, end-stage bladder dysfunction. Of the 73,000 men and women who are diagnosed with bladder cancer each year in the USA, approximately 25% present with invasive or advanced-stage disease, which is often managed using cystectomy. [1] [2] [3] [4] In NMIBC, disease progression or failed endoscopic and/or intravesical approaches to therapy can also necessitate treatment by cystectomy. In men, cystectomy involves removal of the bladder, prostate, and seminal vesicles. In woman, cystectomy typically includes removal of the uterus, ovaries, fallopian tubes, cervix, and the anterior portion of the vagina, although vagina-sparing and organ-sparing procedures are performed in some cases. However, such radical approaches to resection, with removal of these bladder-adjacent anatomical structures, is usually only required in patients with cancer; when performed for benign indications, cystectomy frequently does not include removal of all anterior pelvic structures. Urinary diversion is performed in conjunction with cystectomy to redirect the passage of urine out of the body and is, therefore, an attendant part of the surgery. Three main types of urinary diversion can be used: conduits; continent catheterizable reservoirs; and orthotopic neobladders. Conduit diversions consist of a relatively short segment of bowel, typically distal ileum, that is grafted to transit urine from the ureters to an external collection appliance (bag). As a result, conduit diversions are characterized by an external stoma located on the abdominal wall; however, as they are relatively low maintenance, approximately 80% of patients who undergo cystectomy receive an ileal conduit. 5 By contrast, continent diversions are more complex internal reconstructions that avoid the use of external collection appliances, but might be associated with a greater likelihood of metabolic complications, such as acidosis. 6 More commonly used among younger and healthier patients, continent diversions include catheterizable reservoirs constructed using segments of the ascending colon, as well as orthotopic neobladders that restore volitional voiding. Although continent diversions avoid the necessity of an external collection appliance, they require more diligent maintenance, such as routine catheterization and irrigation. Overall, between 8,000 and 10,000 cystectomy and urinary diversion surgeries are performed each year in the USA. 7 As with other pelvic surgeries, cystectomy is associated with substantial changes in sexual function for both men and women. For example, erectile dysfunction (ED) can affect up to 80% of men after cystectomy and urinary diversion. 8 In addition to the sexual consequences related to iatrogenic ED in men and physical changes (such as altered vaginal anatomy) in women, a number of other factors might also impair sexual function following cystectomy. Body alterations associated with urinary diversion and the resulting changes in body image, the emotional and psychological responses of patients and their partners, as well as social concerns and stigma associated with urinary diversion might impair sexuality and sexual satisfaction, and place strain on intimate relationships. However, although postoperative sexual dysfunction has received considerable attention with regard to some surgical procedures, such as radical prostatectomy, 9 research focused on the sexual function outcomes of cystectomy has been relatively limited to date. As a result, the full extent of the sexual problems that are related to removal of the bladder and urinary diversion remains incompletely understood. We review the current literature regarding patient functioning and health-related quality-of-life (HRQoL) outcomes after cystectomy, focusing in particular on sexual function and dysfunction.
Quality of life and sexual dysfunction
Measures of sexual function and dysfunction are variable, and can include subjective quantitative evaluations of the ability to engage in and the frequency of sexual acts, or objective patient-reported outcomes based on reliable and validated quality-of-life (QoL) assessments. Of these approaches, patient-reported outcomes typically provide the most-accurate and reproducible information, and represent the standard measures of sexual function and dysfunction. A number of indices have been used to assess erectile function and recovery of sexual function after radical pelvic surgery. General QoL inventories enable assessment of sexual function broadly across different medical conditions or surgeries, whereas disease-specific or surgery-specific questionnaires provide more-detailed information regarding the influence and outcomes of the disease and/or its treatment among defined patient populations. Although many tools are available to assess sexual function, most research regarding recovery of sexual function and sexual health in men after cystectomy has been conducted using the International Index of Erectile Function Erectile Function Domain (IIEF-EFD), 10 also known as the IIEF-6, or an abbreviated version of this questionnaire known as the Sexual Health Inventory for Men (SHIM). 11 Both the IIEF-6 and the SHIM questionnaires have cutoff scores for normal erectile function (26 and 21, respectively) with lower scores categorized as mild, moderate, and severe ED. 10, 11 Because erectile function is only one component of sexual dysfunction that can occur after radical cystectomy, however, these surveys do not provide complete information and, therefore, do not enable comprehensive assessment of sexual dysfunction. For women, the counterpart questionnaire most commonly used to evaluate sexual dysfunction is the Female Sexual Function Index (FSFI). 12 Unfortunately, reliable estimates of sexual dysfunction among patients treated with cystectomy might not be available, owing largely to the limited availability or use of psychometrically robust HRQoL questionnaires. In 2005, Porter and Penson 13 published a systematic review of QoL after cystectomy, noting that exceedingly few studies use bladder-cancer-specific HRQoL questionnaires. This systematic review, 13 together with other studies, [14] [15] [16] [17] also underscored the lack of sufficient HRQoL studies in bladder cancer, raising questions regarding the commonly held belief that continent urinary diversions are associated with better QoL outcomes compared with ileal-conduit diversions. However, several questionnaires specifically designed to assess HRQoL in patients with bladder cancer, which were developed to enable accurate quantification of the hallmark issues associated with bladder-cancer treatments, are now available. 20 These indices are increasingly used to survey this patient population.
Key points
■ Sexual dysfunction is a common, but often overlooked, consequence of radical cystectomy in both men and women ■ Sexual dysfunction after radical cystectomy results from a combination of iatrogenic, organic, and psychological factors ■ Health-related quality-of-life surveys specific to patients with bladder cancer have been developed in attempts to better understand the sources of sexual dysfunction ■ Treatment protocols must be tailored to the specific source of sexual dysfunction in each patient and often require both medical treatments and counselling ■ Surgical strategies such as nerve-sparing and vagina-sparing cystectomy might offer improved sexual outcomes while maintaining effective oncological control The first of these indices, FACT-Bl is an extension of the validated general FACT questionnaire, 21 and includes 10 additional items related to urinary, gastrointestinal, and sexual symptoms, and three questions for patients with ostomy appliances (Table 1) . 18, 22 The FACT-VCI is also based on the general FACT questionnaire, but includes 17 adjunct questions specific to bladder cancer and urinary diversion that assess patient experiences after cystectomy. 18, 23 The BCI was the first bladder-cancerspecific QoL questionnaire that was not based on an existing general instrument, and was developed through a series of iterative revisions based on repeat performance evaluations. 24, 25 This questionnaire consists of 36 items that provide insight into urinary, bowel and sexual function, and bother. 24, 25 More recently, the EORTC developed the EORTC QLQ-BLM30 instrument, 20 a bladder-cancer module of their general 30-item QoL questionnaire for patients with cancer (EORTC QLQ-C30). 26 The EORTC QLQ-BLM30 is currently u ndergoing v alidation and, therefore, has not been used widely. 27 Erectile dysfunction after cystectomy ED is a well-known complication of extirpative pelvic surgery and has been previously described among patients treated for colorectal and urological conditions. 28 Although ED is generally acknowledged as a frequent functional consequence of such procedures, definitions of postoperative recovery of erectile function often vary and a standard practical definition of post-pelvic-surgery ED has not been firmly established. This ambiguity has, in part, contributed to the wide-ranging rates of ED that have been described after pelvic surgery. For example, rates as high as 50% and as low as 10% have been reported after radical prostatectomy. 29 Similarly, one of the challenges in evaluating ED after radical cystectomy relates to how erectile recovery is defined; some surgeons and researchers consider the ability to have and maintain erections, or the achievement of erections adequate for intercourse as sufficient criteria for recovery of erectile function, whereas others argue that quality of erections is also an important consideration. The tools used to assess ED highlight some of these challenges. Disease-specific HRQoL questionnaires, such as FACT-Bl and the BCI, often include only one question regarding erectile function. 18, 19 Sexual function inventories such as IIEF-6 and SHIM, 10, 11 although more specific for erectile function, might not include items regarding quality of erections or correlate closely with sexual function outcomes. For example, the questions included in the IIEF focus primarily on penetration, but do not capture information regarding the quality of erections. 10 Thus, other factors influencing sexual function that are frequently overlooked after surgery include the quality and regularity of erections, loss of penile length, preoperative sexual f unction, p sychological issues, and partner-centred factors. 30 Although erectile function has been studied more thoroughly in other urological diseases (such as prostate cancer), some research has examined sexual and erectile function outcomes after radical cystectomy. Allareddy et al. 31 and Gilbert and co-workers 25 outlined a negative effect of cystectomy on erectile function compared with other noncystectomy treatments among patients with bladder cancer (Table 2 ). For example, Allareddy et al. 31 reported that 89% of patients who were treated using radical cystectomy could not maintain an erection follow ing removal of the bladder compared with 32% of patients did not undergo cystectomy. Even among men who regain some erectile function, erections might not be firm enough for intercourse, with studies documenting low rates of return of sufficient erectile function for penetra tion following cystectomy and urinary diversion. 32 Gilbert and colleagues 25 demonstrated worse patient-reported sexual function among patients with bladder cancer treated using cystectomy compared with patients who retained their bladder; BCI sexual function scores among men managed with endoscopic and/or intravesical treatments were approximately 20 points greater than scores for patients managed using cystectomy with ileal-conduit urinary diversion or neobladders (42.2 versus 20.0 and 25.5, respectively). 25 In addition, Månsson and co-workers 33 described marginal erectile function scores before surgery and marked declines in this domain after surgery among Egyptian and Swedish patients with bladder cancer (Table 2) ; average FACT-Bl erectile-function scores, out of a maximum of 4 points, decreased from 2.27 among the Egyptian patients and 2.39 among the Swedish men at baseline to 0.15 and 0.19 at 12 months after surgery in these cohorts, respectively. 33 Furthermore, Karvinen et al. 34 surveyed 392 patients who had undergone cystectomy using the FACT-Bl questionnaire and reported low patient-rated erectile function (1.4 ± 1.4 points out of 4). Other studies in men with bladder cancer have also described both low interest in sexual activity and the inability to maintain erections after cystectomy. 8, 35 Patient age, baseline erectile function, 36 and surgical factors, such as the use of nerve-sparing and orthotopic urinary diversions, seem to be associated with postcystectomy ED (Table 2) . For instance, postcystectomy erections were reported by only one of 31 men with ileal-conduit diversions and by six of 26 men with orthotopic neobladders. 22 In addition, Hedgepeth and colleagues 37 reported modest recovery of sexual function among patients with neobladders, in contrast to declines in sexual functions scores observed after ilealconduit diversion; however, sexual-function scores for the different treatment cohorts were clustered closely and differences were not statistically significant at any postoperative time point. 37 Most importantly, allocation of treatment in this study was not randomized, thus, definitive conclusions are impossible to draw. 37 Indeed, although continent diversions might be associated with a higher likelihood of recovery of sexual function than ileal conduits following cystectomy, confounding factors, such as variations in patient age between treatment cohorts owing to biases in allocation of therapy, complicate detection of a direct, causal link to the type of urinary diversion used. For example, patients with neobladders were an average of 10 years younger than patients who underwent ileal-conduit diversions in the Hedgepeth study 37 (average age 61 years versus 71 years). Other studies have also failed to reliably demonstrate a statistically significant difference in HRQoL or sexual function between diversion approaches. 22, 25, 31, 34, 38, 39 Postcystectomy sexual function in women Sexual dysfunction among women who have undergone cystectomy typically results from neural injury and changes in pelvic anatomy that reduce vaginal capacity, owing to either vaginal foreshortening or narrowing, or alter vaginal lubrication and compliance. These effects of surgery generally lead to dyspareunia. Other factors, such as body image and age-related changes in libido and sexual interest might also contribute to sexual dysfunction reported by women after cystectomy. Zippe and colleagues 40 reported on sexual function in women using the self-administered FSFI, and noted a decrease in total score from 17.4 ± 7.2 at baseline to 10.6 ± 6.6 at a median of 2 years after cystectomy. The most common sexual complaints recorded in this study were inability to achieve orgasm (45%), decreased lubrication (41%), decreased sexual desire (37%), and dyspareunia (22%); 40 less than half of the women were able to partake in sexual intercourse and most reported decreased satisfaction with their sex-life overall. 40 Another study demonstrated that 39% of women reported worse relationships with their husbands after radical cystectomy than before surgery, with 26% stating that they were no longer sexually active. 41 Again, similar complaints of absent libido, dyspareunia, and lack of orgasms were noted. 41 Nevertheless, some women do return to sexual activity following bladder removal. Volkmer and colleges 42 reported that 17 of 29 women (58.6%) remained sexually active after cystectomy, 11 of whom had slightly higher FSFI scores across several domains (desire, arousal, lubrication, orgasm, satisfaction and pain) than before cystectomy, and noted that younger age and partnership were the main factors that influenced female sexuality. Alterations in the surgical approach to cystectomy in women, such as nerve-sparing and vagina-sparing methods, could potentially limit associated vaginal changes. Vagina-sparing procedures should, however, only be pursued in oncologically appropriate cases, and are often contraindicated in patients with bladder cancer involving the urethra, trigone, bladder neck, and/or bladder base or posterior bladder wall. Furthermore, recovery of sexual function after such surgeries is not guaranteed. Although several reports of vagina-sparing cystectomy have been published in the past 5 years, limited information regarding sexual function in this subgroup of patients is available, as most of the reported functional outcomes have focused on control of urinary voiding and continence. 43, 44 One study has reported that 80% of women remained sexually active after vagina-sparing cystectomy. 45 Nerve-sparing cystectomy among woman has also been promoted as an alternative approach to limit the adverse effects of surgery on sexual function. 46 Bhatt et al. 47 reported minimal declines in FSFI scores in a group of six women treated with nervesparing cystectomy (baseline and 12-month postoperative FSFI scores 24.5 and 22.3, respectively) compared with more substantial declines in FSFI scores among seven women treated with non-nerve-sparing approaches (25.0 at baseline versus 11.0 12 months after surgery). Furthermore, Ali-El-Dein and colleagues 48 reported signifi cantly higher FSFI scores among 13 women treated with vagina-sparing and organ-preserving cystectomy compared with 110 women treated with radical c ystectomy (18 ± 1 versus 15 ± 1; P = 0.007).
A recent survey of women with gynaecological or breast cancer noted that, although 42% of the women questioned were interested in receiving information about sexual dysfunction, only 7% asked practitioners for help. 49 However, the barriers to understanding and treating sexual dysfunction extended beyond a reluctance among women to ask for help; 62% of women surveyed in the study reported that no physician ever asked them about the sexual adverse effects of the cancer and the treatment they received. These data suggest that practitioners caring for women with cancer, particularly those with bladder cancer, must be willing to ask their patients about sexual dysfunction and to provide c ounselling resources to help overcome these barriers.
Causes of sexual dysfunction
Although erectile function is the dominant factor driving sexual capacity of men, other important components of normal sexual function (for men and women) include sexual desire and orgasmic function. 50 Although certain HRQoL questionnaires, such as FACT-Bl, 18 do inquire, in broad terms, about interest in sex, the BCI goes further, requesting details about sexual desire, arousal, and sensation, as well as orgasm. 19 Orgasmic dysfunction has not been well-studied among patients who have undergone cystectomy; however, the absence (anorgsmia) or changes in the intensity of orgasms, leakage of urine during orgasm (climacturia), and pain upon orgasm (dysorgsmia) might be important problems in this popu lation, as in men treated with prostatectomy for prostate cancer. 51 Hypogonadism and menopause are other factors potentially influencing sexual function that have been incompletely studied in patients after cystectomy. 50 Symptomatic hypo gonadism affects an estimated 5.6% of men aged 30-79 years and the incidence increases with age, with 18.5% of men aged >60 years reported to have androgen deficiency. 52 Furthermore, a large proportion of postmenopausal women report sexual dysfunction. 53 Successful management of sexual dysfunction following cystectomy depends largely on identifying and addressing the underlying aetiological factors contributing to impaired or suboptimal function. Among men, ED is the most probable and targetable cause; however, other causes of sexual dysfunction, such as depression or anxiety should be evaluated and managed if present. Similarly, the physical and physiological changes associated with cystectomy in women might not be the only contributors to sexual dysfunction. Other factors, such as depression, personal body-image issues, or distress caused by a partner's reaction to an altered body, as well as changes in life course and reprioritization of an individual's sexuality could all potentially have important roles in sexual dysfunction. Indeed, sexual function and dysfunction can be categorized into several domains, and dysfunction can be attributed to organic (physiological), iatrogenic, psychological, and partner-centred causes, or life-course-centred changes (such as reprioritization of sexuality or waning sexual interest). Such disparate aetiologies potentially necessitate different strategies for the management of sexual dysfunction. These domains might be better evaluated using either more general questionnaires that evaluate depression and psychological status, such as the Medical Outcomes Study 36-item Short Form Health Survey, 54 or by more-targeted s ymptom-specific instruments.
Iatrogenic erectile dysfunction
As noted previously, iatrogenic causes of sexual dysfunction after extirpative pelvic surgery are common in men, largely as a result of injury to the cavernous nerves located within the penile neurovascular bundle. Proposed mechanisms of ED include direct nerve injury, neuropathy, inflammation and fibrosis, hormonal changes, and ischaemia. 55 Thus, although most men experience ED and sexual dysfunction after cystectomy and urinary diversion, 45, 46 nerve-sparing and prostate-sparing surgical approaches might limit some of the deleterious consequences associated with removal of the bladder. In fact, nerve-sparing cystectomy has been shown to improve sexual function after cystectomy. For example, Hekai and colleagues 56 demonstrated spontaneous complete penile tumescence in 12 of 21 patients managed with nerve-sparing cystectomy (57.8%); an additional five patients had return of erections with the use of oral phosphodiesterase type 5 (PDE5) inhibitors, whereas the remaining four men required intracavernosal prostaglandin E1 injection therapy to achieve erections. 56 By contrast, all patients treated with non-nerve-sparing cystectomy required injection therapy to achieve erections. 56 In 2004, Zippe et al. 32 evaluated 49 sexually active men who underwent nerve-sparing or non-nervesparing cystectomy, and observed that, overall, only nine of the patients (18.4%) achieved postoperative erections adequate for penetration. Eight of these nine men had undergone nerve-sparing cystectomy; accordingly, half of the 16 men who underwent nerve-sparing cystectomy were able to maintain erectile function, compared with only 1 of 33 (3%) treated with non-nerve-sparing radical cystectomy. 32 Furthermore, Schoenberg and co-workers 57 reported 10-year oncological outcomes of the nervesparing approach that were similar to those that have been reported in studies of non-nerve-sparing surgery, but the frequency of recovery of erectile function among patients who underwent nerve-sparing cystectomy were higher than previously reported after radical cystectomy. Of note, however, return of erectile function post operatively was directly related to patient age, ranging from only 20% in men aged 70-79 years to 62% among patients aged 40-49 years. 57 This finding suggests that inter action between age and precystectomy erectile function could explain, or at least partially contribute to, the difference in outcomes observed between nerve-sparing and non-nerve-sparing surgery. Nevertheless, nerve-sparing cystec tomy is an excellent option in appropriately selected patients, particularly those interested in improving the chance of regaining erectile function postoperatively.
Prostate-sparing and prostate-capsule-sparing cystectomy have also been proposed by some surgeons as a means to preserve erectile function. 58 Initially described among patients undergoing removal of the bladder for noncancerous indications, prostate-sparing and capsulesparing cystectomy are somewhat controversial in the setting of bladder cancer owing to concerns over oncological outcomes. 59 Nevertheless, a number of studies have reported erectile function recovery rates among men with bladder cancer who were treated using prostatesparing cystectomy that were greater than those generally observed after standard cystectomy. In one study of 44 patients, functional erections were maintained in 77.5% of patients after prostate-sparing cystectomy. 60 Similarly, Ong et al. 61 reported 79% erectile function recovery, with or without the need for oral erectile aid medication, follow ing seminal-vesicle-sparing cysto prostatectomy. More recently, Basiri and colleagues 62 reported mean IIEF-5 scores of 19.8 and 5.7 among men r eceiving a prostate-sparing cystectomy and radical cystoprostatectomy, respectively. Mertens and co-workers 63 also demon strated favourable results follow ing prostatesparing cystectomy; in their series of 120 patients treated with prostate-sparing cystectomy, return of erectile function was noted in 89.7% of patients. Potency rates following seminal-vesicle-sparing cystoprostatectomy also appear to limit the functional consequences of more radical surgery; one study 64 reported that 35 of 37 patients managed with seminal-vesicle-sparing cystectomy (95%) maintained erectile function after surgery, and that median IIEF scores decreased relatively minimally from 25 to 21. However, some surgeons continue to caution broad application of prostate-sparing and prostate-capsule sparing approaches, citing concerns and reports of compromised oncological outcomes. 65 Organic sexual dysfunction Age-related and health-related organic erectile and sexual dysfunction might be important determinants of the likelihood of recovery of sexual function after cystectomy, given the advanced age and prevalence of medical comorbidities among the cystectomy population. Organic sexual dysfunction and its underlying causes, such as diabetes, hypertension, and cardio vascular disease, are prevalent in the USA. 66, 67 According to data from the 2001-2002 National Health and Nutrition Examination Survey (NHANES), 66 a cross sectional study of non-institutionalized individuals who were interviewed and examined regarding various health issues, ED affects a considerable proportion of men in the USA across all age groups; more than 18% of the men aged >20 years surveyed reported suffering from ED. 66 Furthermore, as men age and develop other medical conditions, including hypertension and diabetes, ED becomes even more common, affecting around 50% of men with a history of diabetes or cardiovascular disease in the NHANES study. 66 Overall, the prevalence of ED among men aged >70 years is estimated to be as high as 70%. 66 Results from the Massachusetts Male Aging Study 67 report an incidence of 25.9 cases per 1,000 manyears among men between the ages of 40-69 years, with a fourfold increased risk of ED in men aged 60-69 years compared with men aged between 40 and 49 years. As in other studies, the Massachusetts Male Aging Study researchers also noted increased incidences of ED among men with self-reported diabetes and patients who had been treated for either hypertension or heart disease. 67 Most patients with bladder cancer treated using cystectomy and urinary diversion fall within the age groups at high-risk of organic ED, and/or suffer from competing risks factors for organic ED, such as hypertension, diabetes, and smoking-related peripheral vascular disease. Consequently, baseline ED and sexual dysfunction, as well as the presence of medical conditions associated with ED should be considered in evaluations of p ostcystectomy sexual function.
Among women, natural hormonal changes associated with ageing and the onset of menopause seem to be the largest factors associated with female sexual dysfunction. In a large study of more than 31,000 women in the USA, Shifren and colleagues 68 identified varying degrees of low sexual desire, low sexual arousal, and orgasm difficulties, with these issues reported more commonly among middle-age and older respondents; the estimated prevalence of any of these sexual dysfunctions were 44.6% and 80.1% for women aged 45-64 years and ≥65 years, respectively. 68 Health problems, including depression and worse self-assessed health, increased the likelihood of distressing sexual problems, suggesting that women with competing health problems, such as bladder cancer, face additional challenges that can affect sexual function. 68 Psychological causes of sexual dysfunction Psychological distress is relatively common among patients with bladder cancer in the perioperative period. 69 In addition to daily concerns regarding recurrence and disease status, patients with bladder cancer treated using cystectomy and urinary diversion can also face additional stressors related to the consequences of surgery, such as an altered body image. The presence of and adaptation to a urinary stoma, for example, might not only result in body image issues, but can also be a source of additional stress and/or depression. Even among patients with a neobladder, who do not undergo the same degree of body alteration as patients with ileal-conduit diversions, poor control of urinary voiding and incontinence add considerable psychological stress that might limit interest in sexual activity. Although orthotopic diversions have largely been adopted to avoid external body changes (that is, the presence of a stoma) and re-establish volitional urinary function after removal of the bladder, the ability of neobladders to preserve, or improve, body image has not been clearly demonstrated. Using a 102-item QoL questionnaire Gerharz et al. 70 reported higher scores for physical strength, mental capacity, social competence, and leisure activities among patients with continent reservoirs compared with patients with ileal-conduit diversions; however, Hedgepeth and colleagues 37 did not identify higher body-image scores among 139 surveyed patients with neobladders compared to 85 patients ileal-conduits, based on the EORTC Body Image Scale. 71 Månsson et al. 22 studied psychological stress in men after cystectomy with either continent cutaneous diversion or orthotopic bladder substitution using the FACT-Bl and Hospital Anxiety and Depression Scale (HADS). Scores for both depression and anxiety were low and fell within the normal range among these patients overall, and no statistically significant differences in scores were observed between the types of reconstruction. However, issues related to functioning and care of stoma were clearly more applicable to patients with ileal conduits. 22 Thus, the psychological consequences of cystectomy and urinary reconstructions are still relatively poorly understood. Studies have reported conflicting data, and most of the research conducted to date did not specifically address the psychological consequences associated with cystectomy. Nevertheless, potentially relevant information from studies evaluating men with prostate cancer suggests that the causes of sexual dysfunction extend beyond the psychological stress directly associated with the inability to achieve an erection. For example, Wittmann and colleagues 72 explored the psycho logical aspects of ED after prostatectomy, and noted a loss of interest in sexual activity after surgery in some men, not only because of ED-related distress, but also owing to the impaired intimacy and spontaneity resulting from the required use of erectile aids. This report highlights the interplay between iatrogenic, psychological, relationship-related or life-course-related factors that might compound sexual dysfunction in men with ED after pelvic surgery, possibly on a background of organic sexual f unction issues.
Life-course and partner-centred issues Patients with bladder cancer managed with cystectomy can experience changes in both relationships and life priorities, which might be strongly influenced by the physical and psychological causes surrounding sexual dysfunction. For example, Månsson and co-workers 73 studied postoperative life changes in patients after cystectomy and found that, although relationships with friends were unchanged, relationships with spouses or partners were disturbed by sexual problems. In addition, Somani and colleagues 74 interviewed 32 patients before and after cystectomy to identify the most-important factors contri buting to QoL, and the surveyed patients consistently noted family, relationships, health, and finance as important determinants of QoL. Presumably, increased efforts to maintain health, friendships, and family relationships, as well as other factors causing a shift in priorities, might decrease the importance patients place on sexual activity, especially on a background of organic declines in sexual function; however, this aspect has not been well-studied in patients who have undergone cystectomy. Thus, social and life-course factors have important roles in influencing QoL and should, therefore, be addressed during patient counselling.
Partner responses might also be important determinants of sexual activity, as well as general QoL, among patients after cystectomy. An obvious example of a partner-centred issue that can strain intimate relationships and contribute to a dysfunctional sex life is a negative response of the patient's partner to the presence of an external appliance, stoma, or catheterizable channel. Although responses and repulsion of partners have been better-studied among patients with colostomies, such factors associated with an altered body after cystectomy probably also limit intimacy and interest in sexual activities. 75 
Treatment of sexual dysfunction
A detailed description of the management of sexual dysfunction associated with cystectomy and urinary diversion is beyond the scope of this Review. However, that several medical interventions are available for the manage ment of postcystectomy ED is important to note. As for other pelvic surgeries, ED associated with cystectomy can be managed with PDE5 inhibitors, intracorporal injection, transurethral suppositories, or vacuum-pump devices. Among patients in whom such medical therapies are not effective, surgical management with penile prosthesis placement is an alternative effective-albeit invasiveapproach. The majority of the literature on ED after pelvic surgery pertains to prostatectomy, [76] [77] [78] [79] and the efficacy of these ED algorithms have not been well studied in patients treated using cystectomy.
Sexual counselling might serve as an adjunctive therapy to help with adherence to ED therapy. Indeed, sexual counselling has been shown to increase the efficacy of intracorporal-injection therapy, to decrease treatment dropout rates, and to increase the proportion of patients who respond to PDE5 inhibitors alone. 80 Counselling as part of a mutlidisciplinary approach might be required to add ress both male and female factors of sexual dysfunction across multiple causal domains. As described in earlier sections of this Review, a comprehensive approach to uncovering and managing the numerous factors, both organic and nonorganic, that can contribute to sexual dysfunction following cystectomy and urinary diversion might be necessary when counselling this patient population; using HRQoL questionnaires to uncover clinically relevant issues can be invaluable in this regard. In addition, treating physicians should be aware of the sexual issues that can occur after cystectomy and should question and discuss these issues with their patients. Indeed, appropriate patient education, covering multiple aspects of sexual dysfunction, including the availability and use of assistive devices, might also be needed to help patients understand their sexual issues and regain sexual function. 81 
Conclusions
Cystectomy is a commonly performed surgery with considerable effects on QoL. HRQoL surveys can be used to attempt to understand the challenges that face patients after surgery, but these tools tend to have limitations. Sexual impairment and dysfunction is an important problem for both men and women after cystectomy, and affects both the patients and their partners. Such sexual dysfunction results from a combination of organic influences and iatrogenic factors associated with surgery. These issues, combined with psychological stressors (such as body image changes), changes in relationships and life style, and partner-related factors, all contribute to sexual dysfunction. Surgical strategies such as nerve-sparing, prostate-sparing or vagina-sparing cystectomy in appropriately selected patients might provide the best chance for sexual potency after surgery and also the highest probability of success with oral medication for ED. Sexual dysfunction and QoL seem to be similar regardless of whether continent or incontinent urinary diversion is performed with cystectomy. Continued exploration is required to better understand sexual dysfunction and to enable development of algorithms to aid recovery of sexual function after cystectomy.
Review criteria
We searched PubMed for English-language full-text manuscripts and abstracts published between 1990 and 2014. The search terms used, alone and in various combinations, were "cystectomy", "health-related quality of life", "quality of life", and "sexual function". The reference lists of the articles identified were also searched for additional relevant publications.
